PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 38 filers reported holding PROTARA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,138 | -48.6% | 18,047 | -26.5% | 0.00% | – |
| Q2 2023 | $58,670 | +71448.8% | 24,548 | -6.7% | 0.00% | – |
| Q1 2023 | $82 | +3.8% | 26,321 | -11.2% | 0.00% | – |
| Q4 2022 | $79 | -99.9% | 29,626 | -41.0% | 0.00% | – |
| Q3 2022 | $149,000 | -16.3% | 50,207 | -17.4% | 0.00% | – |
| Q2 2022 | $178,000 | -51.9% | 60,784 | -16.0% | 0.00% | – |
| Q1 2022 | $370,000 | -48.4% | 72,350 | -31.9% | 0.00% | – |
| Q4 2021 | $717,000 | -1.2% | 106,245 | +1.3% | 0.00% | – |
| Q3 2021 | $726,000 | -42.4% | 104,918 | -18.9% | 0.00% | -100.0% |
| Q2 2021 | $1,260,000 | +33.1% | 129,380 | +115.2% | 0.00% | 0.0% |
| Q1 2021 | $947,000 | -29.2% | 60,134 | +8.8% | 0.00% | 0.0% |
| Q4 2020 | $1,338,000 | +109.7% | 55,259 | +45.7% | 0.00% | 0.0% |
| Q3 2020 | $638,000 | +135.4% | 37,928 | +310.9% | 0.00% | – |
| Q2 2020 | $271,000 | – | 9,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,674,031 | $13,664,000 | 4.24% |
| Ikarian Capital, LLC | 296,426 | $1,515,000 | 0.20% |
| DLD Asset Management, LP | 229,531 | $1,173,000 | 0.07% |
| Orbimed Advisors | 830,641 | $4,245,000 | 0.07% |
| Boxer Capital, LLC | 209,227 | $1,069,000 | 0.06% |
| Perceptive Advisors | 383,526 | $1,960,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $327,000 | 0.01% |
| Baker Brothers Advisors | 199,671 | $1,020,000 | 0.01% |
| Trexquant Investment LP | 16,313 | $83,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 27,591 | $141,000 | 0.00% |